11 July 2012 - It was reported today that OncoSec Medical Inc (OTCBB:ONCS), a company developing the advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, has chosen the University of California San Francisco as the second enrolling site for its Phase II Merkel...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up